Clinical Outcome of Intravenous Immunoglobulin in the treatment of Guillain Barre Syndrome in a Nepalese Tertiary Centre
Introduction: Intravenous Immunoglobulin is an approved therapy for Guillain Barre Syndrome. Our objective is to understand the management and outcome in Guillain Barre Syndrome patients treated with Immunoglobulin. Materials and Methods: All consecutive patients were retrospectively evaluated in th...
Main Authors: | , |
---|---|
Format: | Article |
Language: | English |
Published: |
HEAD Nepal
2019-06-01
|
Series: | Nepalese Medical Journal |
Subjects: | |
Online Access: | https://www.nepjol.info/index.php/nmj/article/view/24000 |